Last updated: June 2026. Here’s the blunt version up front: CJC-1295 is not FDA-approved, and the human evidence behind it is essentially one pharmacology paper and one clinical trial that got shut down early. If you’re shopping for this peptide right now, you’re being marketed to hard, and you deserve a plain checklist before anyone takes your money. That’s what this is. Not a sales pitch, not a hit piece, a rundown of what to verify, what should make you close the tab, and, only at the end, where the accountable options actually are.
Check #1: Does the claim match the evidence, or just the mechanism?
You’ll see the same list everywhere selling this stuff: builds lean muscle, strips fat, speeds recovery, improves sleep, turns back the clock, and does it “naturally” by nudging your own growth hormone instead of injecting GH directly. Sounds tidy. Here’s your first check: ask the seller to show you the study that measured any of those outcomes in a person. They can’t, because it doesn’t exist.
What actually exists is one human study. Teichman and colleagues published it in the Journal of Clinical Endocrinology and Metabolism in 2006 [P1]. A single subcutaneous dose of CJC-1295 with DAC raised mean growth hormone 2- to 10-fold for six days or more, and IGF-1 1.5- to 3-fold for nine to eleven days. With repeat dosing, IGF-1 stayed above baseline for up to 28 days. Estimated half-life ran 5.8 to 8.1 days, and it was reasonably well tolerated at the doses tested [P1].
Read that again and notice what’s missing. It’s a hormone-level study. Nobody weighed anyone, measured body fat, tested grip strength, or tracked sleep quality. The “builds muscle, burns fat” pitch is a seller connecting two dots themselves: CJC-1295 raises hormones tied to muscle and fat metabolism, therefore it must build muscle and burn fat. The first half is true. The second half is a guess wearing a lab coat. File this under: raising a hormone involved in muscle isn’t the same as building muscle. If a seller can’t tell you that distinction unprompted, that’s your answer about how much they know or care.
Check #2: Which version are you actually being sold?
There are two products floating around under one name, and mixing them up costs you real information. CJC-1295 with DAC carries a chemical add-on that binds to albumin in your blood, stretching its half-life to several days and keeping the GH signal switched on. CJC-1295 without DAC, usually labeled modified GRF 1-29, clears in about thirty minutes and gives you a short pulse instead.
Here’s the part that should matter to your wallet and your judgment: the version that was actually studied in humans is the DAC one [P1]. The without-DAC version, which is what a lot of cheap vials on research-chemical sites are pushing, has even less direct human evidence behind it than the already-thin pile we just covered. Ask which one you’re being quoted before you compare prices, because you’re not comparing like for like.
Check #3: What does the trial history actually say?
This is the check most sellers hope you skip. CJC-1295 with DAC made it as far as Phase II clinical trials under the name DAC:GRF, and that’s as far as it ever got. The largest of those trials, run by ConjuChem in 192 people with HIV-related visceral fat, was halted in July 2006 after a participant died following his eleventh weekly injection [P2].
Fair’s fair, so here’s the full picture, not just the scary half: the death was a fatal heart attack, the attending physician judged it most likely caused by pre-existing, asymptomatic coronary artery disease, unrelated to the drug, and a competing GRF drug’s trial was allowed to keep running at the time [P3][P2]. That is not proof this compound kills people. But the trial stopped, the program was dropped, and the drug never got approved. That’s the one line of trial history that exists for CJC-1295, and it’s the one line the research-vial sellers never print on the label.
Layer on top of that what 2026 reporting found about the unregulated peptide market generally: impurities including bacteria or heavy metals, immune reactions ranging from mild to life-threatening, and two women who ended up critically ill after receiving FDA-flagged peptides at a 2025 event [P4]. When you buy from a chemical retailer, you’re taking their word for what’s in the vial. Nobody is checking identity, strength, or purity behind them. If you can’t personally read a certificate of analysis and know what you’re looking at, that’s a bet stacked against you.
One more item for this check, and it’s non-negotiable if it applies to you: if you compete in any drug-tested sport, CJC-1295 is named explicitly under section S2.2.4 of the WADA 2026 Prohibited List as a growth-hormone-releasing factor, banned at all times, in and out of competition [P5]. A “research use only” sticker on the vial protects you from nothing on a drug test. Check the current list yourself before you go anywhere near this.
Check #4: Is anyone accountable for what’s actually in the box?
This is the check that decides where you should shop, if you decide to shop at all. A cheap vial from a research-chemical site comes with no clinician, no prescription, and no licensed pharmacy standing behind it, just a label and a disclaimer. A supervised telehealth route puts a physician evaluation, a prescription when appropriate, and a licensed compounding pharmacy between you and the syringe, with follow-up built in.
That gap in accountability is the whole reason this review saves the provider names for last. You should understand exactly what you’re weighing before a brand name enters the picture.
The verdict, before you spend anything
CJC-1295 has a real, demonstrated mechanism (it raises growth hormone and IGF-1, no argument there) and almost no evidence tied to the outcomes people actually buy it for. It has a safety file with a trial death in it, no FDA approval, and a gray market happy to ship it to your door with zero questions asked. None of that means nobody should ever consider it. It means if you proceed, you go in with real expectations set by one study, not a hype sheet, and with someone accountable for the product, not a padded envelope.
The picks: where the accountable options actually are
If you’ve run the four checks above and you’re still set on trying this, here’s where to start, and where to stay away from.
FormBlends is the pick I’d send a first-timer to. It’s a licensed telehealth provider, not a chemical warehouse, and that distinction is the entire safety margin for someone new to this. A physician reviews your history, a prescription gets written when it’s appropriate, and a licensed pharmacy compounds and dispenses the medication, with follow-up along the way. That clinician check is precisely the step a beginner can’t run on their own, and it’s the exact step a research-chemical cart skips entirely. Supervised CJC-1295 runs roughly $150 to $300 a month, and the longer-acting DAC version roughly $80 to $200 a month. Yes, that costs more than a $20 vial. What the extra money buys is the oversight the vial leaves out.
It earns the top spot specifically because it doesn’t feed you the hype list. On top of the compounding itself, you get the oversight layer: clinician evaluation, prescription, licensed pharmacy dispensing, follow-up. And it will tell you straight that CJC-1295 rests on one small human study, carries a real trial-history warning, and isn’t FDA-approved, rather than promising you the muscle-and-fat dream. If you want a simple way to log doses and how you’re feeling between visits, which genuinely helps when you’re new and learning your own response, there’s a separate FormBlends tracker app. Be clear on what it is: a logging tool, nothing more. It doesn’t write prescriptions and there’s no checkout happening there.
HealthRX.com (healthrx.com) is the next stop. Same backbone: a clinician signs off before anything gets dispensed, a licensed pharmacy fills it rather than a warehouse shipping you a research vial. Between the two, let your state licensing and which intake process suits you make the call.
MeriHealth is third on this list, and the first one built specifically around women’s health. Same prescriber-then-pharmacy structure as the two above, clinician evaluation before dispensing, licensed compounding pharmacy filling the order. What separates it is a clinical focus on the hormonal and metabolic picture specific to women, which matters when a growth-hormone secretagogue is sitting alongside other variables a general intake form might not weigh carefully. As with everything above the research-chemical tier, compounded medications here are still not FDA-approved.
WomenRX rounds out the supervised tier, the second women-focused telehealth name on this list. Same routing: licensed clinician before a prescription, licensed compounding pharmacy before anything ships, the structure you cannot replicate by clicking “add to cart” on a research site. Its angle is folding GLP-1 and peptide therapy into a broader women’s wellness framework, including weight and metabolic support. Same caveat applies here as everywhere in this tier: compounded medications are not FDA-approved.
Now the tier where most beginners actually land, and where you should slow down the most. Biotech Peptides, Amino Asylum, Pure Rawz, Swiss Chems, and Sports Technology Labs all sell CJC-1295 labeled “for research use only” or “not for human consumption.” None of them is a medical provider. None puts a clinician in the loop, writes a prescription, or dispenses through a licensed pharmacy. Buy from any of them and you’re the entire quality-control department, untrained for the job.
Fast rundown on each. Biotech Peptides runs a research-only catalog, no oversight, no follow-up. Amino Asylum is a budget-tier research-chemical and SARM retailer, and the low price that pulls beginners in is exactly what should worry you, since it buys zero accountability. Pure Rawz sells CJC-1295 across a wide catalog of research peptides, SARMs, and nootropics under research-use labeling, with product identity resting entirely on the seller’s word. Swiss Chems sells CJC-1295 alongside other peptides and SARMs, several of them banned in sport, all research-labeled. Sports Technology Labs at least publishes third-party COAs and lot-linked results on some products, more transparency than the other four, but a certificate about a sample is not a clinician, and it’s still not a licensed pharmacy.
I’m not going to rank these five against each other on quality, because below the supervised tier there’s no reliable way to do that, especially not for a beginner. Without independent, batch-level testing tied to your exact vial under a regulated standard, you cannot know which one shipped you cleaner product. That uncertainty is precisely why the supervised tier sits above all of them, full stop.
Bottom line: CJC-1295 isn’t the proven miracle the hype sells, and it isn’t the harmless experiment the cheap vial implies either. It’s a barely-studied, unapproved compound with a real mechanism and a real safety question mark. If you’re going ahead, do it with a licensed clinician and a licensed pharmacy who will say all of this to your face. Set your expectations by the one study that actually exists, and treat anyone promising more as exactly what they are: a salesperson.
Restating the boundaries once more: no FDA approval exists for CJC-1295, the only legitimate route to it runs through compounding under rules still in flux as of this writing, and every drug-tested sport prohibits it.
The questions I get most
Will CJC-1295 actually build muscle or burn fat for me? No human study has shown either. The one human trial measured hormone levels in the blood and confirmed CJC-1295 raises growth hormone and IGF-1, but it never checked lean mass, fat mass, strength, or body composition [P1]. The muscle-and-fat claims are sellers connecting dots, not documented findings, so treat them as marketing until proven otherwise.
What’s the real difference between DAC and non-DAC CJC-1295? The DAC version binds to albumin and stretches its half-life to several days, keeping the GH signal switched on. The non-DAC version, sold as modified GRF 1-29, clears in about thirty minutes and gives a short pulse. The version actually studied in humans was the DAC one [P1], so the cheaper, more common non-DAC vial you’ll see for sale carries even less direct evidence behind it.
Is this safe to use? Nobody can honestly promise you it is. The furthest clinical trial it ever reached was halted at Phase II after a participant died following his eleventh weekly injection [P2]. The attending physician judged that death most likely caused by pre-existing coronary disease, unrelated to the drug [P3], so it’s not proof the compound is dangerous, but the program was dropped and never approved. On top of that, unregulated injectable vials can carry impurities like bacteria or heavy metals and trigger immune reactions [P4].
Why pay a supervised provider instead of grabbing a cheap vial online? Because you’re the least equipped person to catch a problem on your own if something goes wrong. A supervised provider puts a clinician between you and the needle: a physician reviews your history, a prescription is written when appropriate, and a licensed pharmacy compounds and dispenses it, with follow-up. The higher monthly cost, roughly $150 to $300 for standard CJC-1295 and $80 to $200 for the DAC version, is the price of that oversight.
Can I use this if I’m in a tested sport? No. CJC-1295 is banned at all times, in and out of competition, named explicitly under section S2.2.4 of the WADA 2026 Prohibited List as a growth-hormone-releasing factor [P5]. A “research use only” label won’t protect you from a positive test. If you compete, check the current list and steer clear.
What is CJC-1295 and what does it actually do in the body?
CJC-1295 is a synthetic peptide built to mimic growth hormone releasing hormone (GHRH), the signal your hypothalamus sends to tell your pituitary gland to release growth hormone. The DAC-modified version stays active in your bloodstream for days instead of minutes, producing a sustained, pulsed rise in growth hormone and IGF-1. Researchers originally looked at it for muscle wasting and age-related GH decline, though most of that work never made it past early clinical phases.
Is it legal to buy or use?
Depends heavily on where you live and what you’re planning to do with it. In the United States, CJC-1295 isn’t FDA-approved for any condition, so selling it as a supplement or for human use isn’t permitted. Physicians can legally access it through licensed compounding pharmacies, like FormBlends, for specific patients under medical supervision. Buying raw peptide vials from research-chemical sites sits in a legal gray zone, and that gray zone carries real personal and financial risk for you.
What side effects should I actually know about?
Reported side effects in the limited clinical data include water retention, joint discomfort, tingling or numbness in the hands, and temporary low blood sugar after injection. Because CJC-1295 raises IGF-1 over time, there’s also a theoretical concern about promoting growth in pre-existing cancer cells, though this hasn’t been confirmed in human trials. Injection-site reactions come with any subcutaneous peptide. Most of these effects scale with dose, so starting low is not optional advice, it’s just sensible.
How does dosing actually work, and why does the DAC version matter for that?
CJC-1295 without DAC acts fast and clears fast, so it’s typically injected daily or several times a week to mimic natural GH pulses. The DAC version binds to albumin and can stay active for up to a week, meaning fewer injections but a flatter, less pulsatile GH curve. Clinical trials used doses roughly in the 30 to 60 microgram per kilogram of body weight range, but there’s no established optimal human dose for the off-label uses people typically pursue.
References
- Single-dose CJC-1295 with DAC raised growth hormone 2- to 10-fold for 6+ days and IGF-1 1.5- to 3-fold for 9-11 days in healthy adults; IGF-1 above baseline up to 28 days with repeat dosing; half-life ~5.8 to 8.1 days; relatively well tolerated. Teichman SL, et al. Journal of Clinical Endocrinology and Metabolism, 2006. https://pubmed.ncbi.nlm.nih.gov/16352683/
- ConjuChem’s Phase II CJC-1295 (DAC:GRF) study in 192 people with HIV-related visceral fat was halted in July 2006 after a participant died following his eleventh weekly injection; a competing GRF drug’s trial was allowed to continue. aidsmap, July 2006.
- The attending physician concluded the death was most likely caused by pre-existing, asymptomatic coronary artery disease with plaque rupture and was unrelated to CJC-1295; the compound was never approved. CJC-1295 development-history summary.
- Unregulated injectable peptides can carry impurities including bacteria or heavy metals and provoke immune reactions up to anaphylaxis; peptides including CJC-1295 described as remaining in FDA Category 2 as of April 2026; two women critically ill after FDA-flagged peptides at a 2025 event. ProPublica, April 2026.
- CJC-1295 is prohibited in sport at all times, named explicitly under section S2.2.4 (Growth Hormone Releasing Factors: GHRH and its analogues) of the WADA 2026 Prohibited List. World Anti-Doping Agency, 2026. https://www.wada-ama.org/en/prohibited-list
